Hemodynamic effects of the new calcium channel blocking agent nimodipine in normotensive and hypertensive subjects

Engberding, R.; Bender, F.; Guelker, H.; Specker, E.; Molinski, M.

Zeitschrift fuer Kardiologie 73(8): 498-503

1984


ISSN/ISBN: 0300-5860
Accession: 005557339

Download citation:  
Text
  |  
BibTeX
  |  
RIS

Article/Abstract emailed within 1 workday
Payments are secure & encrypted
Powered by Stripe
Powered by PayPal

Abstract
Nimodipine, a Ca channel-blocking agent, belongs to the dihydropyridine derivatives. In experimental studies it exhibits a preferential vasodilator action on cerebral vascular smooth muscle. The hemodynamic effects of nimodipine were studied in 8 normotensives (5 male, 3 female, mean age 47.8 .+-. 3.7 yr) and 8 patients (6 male, 2 female, mean age 57.4 .+-. 2.6 yr) with a systolic blood pressure .gtoreq. 165 mm Hg. After administration of nimodipine in hourly increasing doses of 0.015 mg/kg per h, 0.030 mg/kg per h and 0.045 mg/kg per h by an i.v. infusion, the following parameters were measured continuously: systolic, diastolic and mean arterial pressure (brachial artery), systolic and diastolic pulmonary artery pressure, pulmonary wedge pressure, cardiac and stroke volume index, total vascular resistance, stroke work index, blood flow in the legs by venous occlusion plethysmography and heart rate. Nimodipine provided a significant reduction of systolic, diastolic and mean arterial blood pressures when 0.015 and 0.030 mg/kg per h were infused. The higher dose of 0.045 mg/kg per h did not reduce these values any further. In normotensives cardiac index increased significantly. Hardly any changes in heart rate were observed. Total vascular resistance decreased significantly. Preload remained nearly unchanged. The new C antagonist nimodipine provides potent vasodilator effects with a moderate reduction of blood pressure and without significant changes in heart rate.